{"id":22972,"date":"2020-12-10T09:57:23","date_gmt":"2020-12-10T08:57:23","guid":{"rendered":"https:\/\/www.satt.fr\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/"},"modified":"2020-12-10T09:57:23","modified_gmt":"2020-12-10T08:57:23","slug":"lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/","title":{"rendered":"LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous !"},"content":{"rendered":"<div class=\"fusion-text fusion-text-3 intro-article\">\n<p><em>Proposer des tests de diagnostic de haute qualit\u00e9, accessibles \u00e0 tous, partout et \u00e0 tout moment, telle est l\u2019ambition de la start-up LumediX fond\u00e9e en 2018. Son innovation : une technologie bas\u00e9e sur des nanoparticules luminescentes \u00e0 base de terres rares, qui permet d\u2019augmenter la sensibilit\u00e9 des tests de diagnostics m\u00e9dicaux. Particuli\u00e8rement active dans le domaine des maladies infectieuses, LumediX d\u00e9veloppe aujourd\u2019hui des tests rapides sur bandelettes, avec un diagnostic disponible en 15 minutes.<\/em><\/p>\n<\/div>\n<div class=\"fusion-text fusion-text-4\">\n<ul>\n<li><strong>De l\u2019id\u00e9e\u2026\u00e0 la cr\u00e9ation de votre start-up, comment est n\u00e9e Lumedix\u00a0?<\/strong><\/li>\n<\/ul>\n<p><strong>Maximilian Richly\u00a0:\u00a0<\/strong>L\u2019origine date de mes travaux de th\u00e8se sur la structure membranaire des cellules au sein de l\u2019\u00c9cole polytechnique. Nous utilisions, dans le cadre de ces recherches fondamentales, des technologies \u00e0 base de nanoparticules luminescentes. L\u2019id\u00e9e est alors venue d\u2019utiliser les propri\u00e9t\u00e9s physico-chimiques uniques de ces nanoparticules pour des applications m\u00e9dicales, notamment au sein des tests de diagnostic in vitro en vue d\u2019am\u00e9liorer leur performance. La cr\u00e9ation de LumediX s\u2019est ensuite r\u00e9alis\u00e9e au fil du temps, apr\u00e8s de nombreuses formations entrepreneuriales et deux phases d\u2019acc\u00e9l\u00e9ration au sein de l\u2019acc\u00e9l\u00e9rateur de l\u2019\u00c9cole polytechnique. En parall\u00e8le, nous avons poursuivi le d\u00e9veloppement de notre technologie avec le soutien de la SATT Paris-Saclay qui a accompagn\u00e9 la maturation de notre projet de tests Point-of-care. Nous sommes d\u2019ailleurs particuli\u00e8rement reconnaissants du r\u00f4le jou\u00e9 par la SATT au sein de cette aventure.<\/p>\n<ul>\n<li><strong>Vous dirigez votre start-up en bin\u00f4me, quels sont les avantages\u00a0?<\/strong><\/li>\n<\/ul>\n<p><strong>Maximilian Richly\u00a0:\u00a0<\/strong>J\u2019ai rencontr\u00e9 Thibaut Mercey au sein de l\u2019acc\u00e9l\u00e9rateur de Polytechnique. A l\u2019\u00e9poque, c\u2019\u00e9tait l\u2019un de mes mentors pour l\u2019aspect business et gestion d\u2019entreprise. De son c\u00f4t\u00e9, Thibaut souhaitait s\u2019impliquer dans un nouveau projet entrepreneurial. Ensemble, nous avons co-fond\u00e9 LumediX en 2018. Notre association repose sur une forte compl\u00e9mentarit\u00e9. Thibaut, issu d\u2019une formation en optique physique et fortement exp\u00e9riment\u00e9 en cr\u00e9ation d\u2019entreprise, encadre la partie instrumentale, algorithmique et traitement des images. De mon c\u00f4t\u00e9, je me charge de la partie biochimie, nanoparticules et d\u00e9veloppement des tests. Et nous nous partageons toute la gestion administrative de l\u2019entreprise. Un gain de temps de taille !<\/p>\n<ul>\n<li><strong>Des projets en cours dont vous pouvez nous parler\u00a0?<\/strong><\/li>\n<\/ul>\n<p><strong>Maximilian Richly :\u00a0<\/strong>Nous avons plusieurs projets de tests en cours d\u2019\u00e9laboration pour r\u00e9pondre \u00e0 la demande de nos clients. En parall\u00e8le, nous d\u00e9veloppons des tests au nom de LumediX. C\u2019est le cas pour des tests de diagnostic de plusieurs maladies infectieuses, au premier titre desquelles la Tuberculose : c\u2019est d\u2019ailleurs un projet central pour l\u2019entreprise, qui a \u00e9t\u00e9 g\u00e9n\u00e9reusement soutenu par la Fondation Jean-Jacques et Felicia Lopez-Loreta, Bpifrance, et la r\u00e9gion \u00cele-de-France, et que nous souhaitons d\u00e9ployer en particulier en Afrique et au sein de pays en voie de d\u00e9veloppement, o\u00f9 l\u2019acc\u00e8s pour tous et partout \u00e0 un test rapide a beaucoup plus de sens qu\u2019un test r\u00e9alis\u00e9 en laboratoire. Pour participer \u00e0 la lutte contre la pand\u00e9mie actuelle de Covid-19, nous avons \u00e9galement \u00e9labor\u00e9 un test sp\u00e9cifique. Nous sommes actuellement en phase avanc\u00e9e de d\u00e9veloppement et d\u00e9butons son industrialisation. L\u2019avantage est qu\u2019il permettra de proposer un diagnostic de tr\u00e8s forte sensibilit\u00e9 en seulement 15 minutes, n\u2019importe o\u00f9.<\/p>\n<p><strong>Maximilian Richly<br \/>\n<\/strong><strong>CEO Lumedix<\/strong><\/p>\n<\/div>\n<p style=\"text-align: center;\"><a href=\"https:\/\/satt-paris-saclay.fr\/deeptech-succes\/lumedix\/\" target=\"_blank\" rel=\"noopener\">D\u00e9couvrir LumediX<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Proposer des tests de diagnostic de haute qualit\u00e9, accessibles \u00e0 tous, partout et \u00e0 tout moment, telle est l\u2019ambition de la start-up LumediX fond\u00e9e en 2018. Son innovation : une technologie bas\u00e9e sur des nanoparticules luminescentes \u00e0 base de terres rares, qui permet d\u2019augmenter la sensibilit\u00e9 des tests de diagnostics m\u00e9dicaux. Particuli\u00e8rement active dans le [&hellip;]<\/p>\n","protected":false},"author":18,"featured_media":22849,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,604],"tags":[],"class_list":["post-22972","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-startup-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous ! - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lydwine heneault\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/\"},\"author\":{\"name\":\"Lydwine heneault\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6b4a6e71701d457ee52e95f35a468fd6\"},\"headline\":\"LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous !\",\"datePublished\":\"2020-12-10T08:57:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/\"},\"wordCount\":592,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Max-Richly-Test.jpg\",\"articleSection\":[\"News\",\"Start-up\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/\",\"url\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/\",\"name\":\"LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous ! - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Max-Richly-Test.jpg\",\"datePublished\":\"2020-12-10T08:57:23+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6b4a6e71701d457ee52e95f35a468fd6\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Max-Richly-Test.jpg\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Max-Richly-Test.jpg\",\"width\":2231,\"height\":1250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous !\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6b4a6e71701d457ee52e95f35a468fd6\",\"name\":\"Lydwine heneault\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/lydwine\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous ! - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/","twitter_misc":{"Written by":"Lydwine heneault","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/"},"author":{"name":"Lydwine heneault","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6b4a6e71701d457ee52e95f35a468fd6"},"headline":"LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous !","datePublished":"2020-12-10T08:57:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/"},"wordCount":592,"image":{"@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Max-Richly-Test.jpg","articleSection":["News","Start-up"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/","url":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/","name":"LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous ! - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Max-Richly-Test.jpg","datePublished":"2020-12-10T08:57:23+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6b4a6e71701d457ee52e95f35a468fd6"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Max-Richly-Test.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Max-Richly-Test.jpg","width":2231,"height":1250},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/lumedix-des-tests-de-nouvelle-generation-accessibles-a-tous\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"LumediX, des tests de nouvelle g\u00e9n\u00e9ration accessibles \u00e0 tous !"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6b4a6e71701d457ee52e95f35a468fd6","name":"Lydwine heneault","url":"https:\/\/www.satt.fr\/en\/author\/lydwine\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/22972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=22972"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/22972\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/22849"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=22972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=22972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=22972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}